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There is a lively discussion going on as to whether 
oxidative stress is or is not a cause of (accelerated) 
aging, fuelled to a significant extent by the finding from 
Arlan Richardson’s group that mice heterozygous for 
the mitochondrial superoxide dismutase SOD2  showed 
increased oxidative stress, increased cancer incidence 
but not accelerated ageing [1].  A new twist to this story 
was introduced recently when it was shown that 
connective tissue-specific SOD2 knockouts developed 
multiple signs of progeria including short lifespan, 
associated with up-regulation of the cell senescence 
marker p16
INK4A [2]. Mitochondrially generated 
oxidative stress is both an established cause [3] and a 
relevant consequence [4] of cell senescence, frequencies 
of senescent cells in connective tissue increase during 
mice aging [5], and destruction of senescent cells can 
‘cure’ some age-related tissue dysfunction [6]. A paper 
by Judith Campisi’s and Simon Melov’s  groups 
recently published in Aging [7] now further explores the 
connection between oxidative stress, cell senescence 
and aging.  The authors demonstrate that mitochondrial 
dysfunction occurs in the epidermis of old (2 years) 
mice, measured as decreased complex II activity, and 
correlate this with increased senescence (shown by SA-
bGAL activity) in the stratum corneum. Moreover, they 
observe the same senescence phenotype in skin from 
young (17 – 20 days old) constitutive SOD2-/- mice, 
which were treated with the synthetic SOD and catalase 
mimetic EUK-189 in order to allow sufficient 
development to take place for a skin phenotype to 
develop.  An increase of various senescence markers in 
the epidermis, the stratum corneum or the lining of the 
hair follicles was associated with epidermal thinning (a 
classical aging marker in skin) and increased expression 
of a keratinocyte terminal differentiation marker [7].   
These data enforce two central hypotheses in the field, 
namely that of mitochondrial dysfunction as a cause of 
cell senescence, and of cell senescence as a relevant 
contributor to mammalian aging in vivo. 
 
However, a fascinating question remains: Is it really 
Reactive Oxygen Species (ROS) arising from 
mitochondria that promote cellular senescence in this 
model?  Mitochondria  from  SOD2-/- mice  accumulate  
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superoxide in their matrix space which oxidizes and 
damages multiple mitochondrial enzyme complexes, 
leading to decreased oxygen uptake and ATP 
production and lowered complex II activity [8, 9]. 
However, superoxide cannot cross the mitochondrial 
inner membrane, and the generation of hydrogen 
peroxide, which is the only membrane-permeable ROS, 
is greatly reduced by two factors, the absence of the 
mitochondrial SOD and the decrease in oxygen uptake. 
Thus, SOD2-/- mitochondria actually release less ROS 
than wild-type mitochondria into their environment
9. 
This is attenuated by the addition of the superoxide 
mimetic EUK-189, but even under high drug 
concentrations the ROS release from heart mitochondria 
was below wild-type levels [9]. Thus, it is not at all 
clear that mitochondrial oxidative stress directly 
produces cellular oxidative stress in the skin of EUK-
189 treated SOD2-/- mice. Importantly, studies have 
shown that mitochondrial dysfunction in SOD2-/- 
fibroblasts is associated with Ca
2+ signal transduction, 
suppression of signals through the mTOR axis and 
induction of markers of autophagy [8]. All these 
changes are characteristically associated with cell 
senescence [3, 10, 11]. Thus, we are again left with a 
chicken-and egg situation: Is disrupted Ca
2+ signalling, 
reduced mTOR activity and increased autophagy found 
in SOD2-/- cells because there are more senescent cells 
in the examined population? Or is any of these factors 
the culprit that triggers senescence in the first place?  
 
While the answer to these questions still eludes us, the 
study from Campisi and colleagues highlights the 
importance of mitochondrial dysfunction and cellular 
senescence in vivo and its impact on the aging process.  
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